Is Walgreens Boots Alliance a buy or sell?

Walgreens Boots Alliance Stock Forecast FAQ Out of 11 analysts, 2 (18.18%) are recommending WBA as a Strong Buy , 0 (0%) are recommending WBA as a Buy, 6 (54.55%) are recommending WBA as a Hold, 1 (9.09%) are recommending WBA as a Sell, and 2 (18.18%) are recommending WBA as a Strong Sell.

What is the difference between Walgreens and Walgreens Boots Alliance?

Walgreens Boots Alliance, Inc. (WBA) is an American multinational holding company headquartered in Deerfield, Illinois, which owns the retail pharmacy chains Walgreens in the US and Boots in the UK, as well as several pharmaceutical manufacturing and distribution companies.

What is the WBA prediction?

Based on 12 Wall Street analysts offering 12 month price targets for Walgreens Boots Alliance in the last 3 months. The average price target is $13.67 with a high forecast of $22.00 and a low forecast of $9.00 . The average price target represents a 16.84% change from the last price of $11.70.

What is the highest Walgreens stock has ever been?

The all-time high Walgreens stock closing price was 68.38 on August 05, 2015 . The Walgreens 52-week high stock price is 27.05, which is 203.6% above the current share price. The Walgreens 52-week low stock price is. The average Walgreens stock price for the last 52 weeks is 18.64.

Will Walgreens make a comeback?

Walgreens' financial performance is still rocky, but experts agree there is a good chance that CEO Tim Wentworth can lead the company to recovery . To make this happen, Walgreens will have to let go of its retail clinic dreams and focus more on making its core pharmacy business as strong as possible.

What is the future of Walgreens Boots Alliance?

Future Growth Walgreens Boots Alliance is forecast to grow earnings and revenue by 84.1% and 1.4% per annum respectively .

Why is Walgreens stock so low?

The simple reason Walgreens stock is so low is because of its falling stock price . WBA stock has lost 85% of its value in the last 10 years. In fact, its stock price was in the $60s when it joined the Dow in 2018, compared to the $20s when it was ousted from the index earlier this year.

What is Walgreens Boots Alliance ranked in the world?

This makes Walgreens Boots Alliance the world's 2060th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

What is the fair value of Walgreens Boots Alliance?

As of 2024-09-10, the Fair Value of Walgreens Boots Alliance Inc (WBA) is -168.31 USD . This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.91 USD, the upside of Walgreens Boots Alliance Inc is -1989%.

What is the dividend growth rate for Walgreens Boots Alliance?

WBA (Walgreens Boots Alliance) 5-Year Dividend Growth Rate : 3.00% (As of May. 2024)

Why did Walgreens want to sell boots?

Walgreen Boots Alliance first attempted to sell Boots in 2022 but abandoned the idea after it failed to find a suitable buyer. The company cited “ unexpected and dramatic” changes in market conditions as key reasons.

What is Walgreens Boots Alliance Inc Moody's rating?

Company Overview Revenues International 16% Standard & Poor's/Moody's BB/Ba3 MSCI ESG Rating A/Average Walgreen's debt ratings from both Standard and Poor's and Moody's are below investment grade.

Walgreens Boots Alliance Stock Price | WBA Stock Quote, News, and History

New: Online Broker Comparison!Learn more about the best online brokers in our new comparison! Find out more!

On Monday 06/17/2024 the closing price of the Walgreens Boots Alliance Inc share was $16.13 on BTT.Compared to the opening price on Monday 06/17/2024 on BTT of $15.15, this is a gain of 6.08%.Walgreens Boots Alliance Inc's market capitalization is $13.09 B by 862.71 M shares outstanding.

Is Walgreens Boots Alliance stock a Buy, Sell or Hold?

Walgreens Boots Alliance stock has received a consensus rating of hold. The average rating score is and is based on 5 buy ratings, 36 hold ratings, and 9 sell ratings.

What was the 52-week low for Walgreens Boots Alliance stock?

The low in the last 52 weeks of Walgreens Boots Alliance stock was 14.62. According to the current price, Walgreens Boots Alliance is 110.12% away from the 52-week low.

What was the 52-week high for Walgreens Boots Alliance stock?

The high in the last 52 weeks of Walgreens Boots Alliance stock was 32.87. According to the current price, Walgreens Boots Alliance is 48.98% away from the 52-week high.

What are analysts forecasts for Walgreens Boots Alliance stock?

The 50 analysts offering price forecasts for Walgreens Boots Alliance have a median target of 34.46, with a high estimate of 54.00 and a low estimate of 13.00. The median estimate represents a 46.72 difference from the last price of 16.10.

Walgreens Boots Alliance Stock Snapshot

16.11

Bid

4,600.00

Bid Size

16.14

Ask

200.00

Ask Size

6/18/2024

Date

7:31 PM

Time

1.10 M

Volume

16.13

Prev. Close

15.15

Open

13.08 B

Market Cap in USD

Walgreens Boots Alliance NewsMore News

Markets Insider Automation16h

Walgreens Boots Alliance Inc hosts conference call for investors

InvestorPlace20h

3 Must-Buy Stocks for Long-Term Gains: June 2024

InvestorPlace20h

DOC, VZ, APAM: 6% Dividend-Yielding Bargains to Buy Now

TipRanks1d

Walgreens Boots Alliance (WBA) Receives a Hold from Mizuho Securities

InvestorPlace1d

Historical Prices for Walgreens Boots Alliance

Loading..
Date	Open	Close	Daily High	Daily Low

Price change over selected period:0%0

Walgreens Boots Alliance Analyst Data

Total Analysts: 50

Buy Ratings: 5 Neutral Ratings: 36 Sell Ratings: 9

Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}

Price *Price Target

Lowest: 13.00 Median: 34.46 Highest: 54.00

*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

Walgreens Boots Alliance Analyst Opinions

All
Buy
Hold
Sell

Date	Analyst	Rating	Price
06/03/24	Evercore	Maintained Hold	$17	neutral
05/31/24	Morgan Stanley	Maintained Sell	$13	schlecht
04/03/24	Deutsche Bank	Maintained Hold	$22	neutral
04/03/24	UBS	Maintained Hold	$22	neutral
04/01/24	Morgan Stanley	Maintained Sell	$20	schlecht
03/26/24	Raymond James Financial, Inc.	Maintained Hold		neutral
03/26/24	Morgan Stanley	Maintained Sell	$21	schlecht
03/26/24	Bank of America Merrill Lynch	Maintained Sell	$22	schlecht
02/20/24	HSBC	Downgraded to Sell	$20	schlecht
12/22/23	HSBC	Maintained Sell	$27	schlecht
10/23/23	J.P. Morgan	Upgraded to Buy	$30	gut
10/13/23	RBC Capital Markets	Maintained Hold	$26	neutral
10/10/23	Mizuho	Maintained Hold	$25	neutral
10/05/23	J.P. Morgan	Maintained Hold	$27	neutral
09/22/23	Deutsche Bank	Maintained Hold	$27	neutral
08/24/23	Credit Suisse	Maintained Hold	$30	neutral
07/14/23	Mizuho	Maintained Hold	$31	neutral
06/29/23	RBC Capital Markets	Maintained Hold	$29	neutral
06/28/23	Mizuho	Maintained Hold	$35	neutral
06/28/23	J.P. Morgan	Maintained Hold	$35	neutral
06/28/23	Barclays Capital	Maintained Hold	$32	neutral
06/28/23	Credit Suisse	Maintained Hold	$33	neutral
06/28/23	Deutsche Bank	Downgraded to Hold	$34	neutral
06/26/23	Morgan Stanley	Maintained Sell	$37	schlecht
06/13/23	Mizuho	Maintained Hold	$35	neutral
03/30/23	Deutsche Bank	Maintained Buy	$46	gut
03/29/23	UBS	Maintained Hold	$37	neutral
03/29/23	Mizuho	Maintained Hold	$41	neutral
03/29/23	J.P. Morgan	Maintained Hold	$43	neutral
03/27/23	Barclays Capital	Maintained Hold	$43	neutral
03/22/23	Evercore	Maintained Hold	$35	neutral
02/23/23	Loop Capital	Maintained Buy	$45	gut
01/30/23	Morgan Stanley	Maintained Sell	$37	schlecht
01/06/23	J.P. Morgan	Maintained Hold	$40	neutral
01/06/23	Credit Suisse	Maintained Hold	$41	neutral
12/14/22	Mizuho	Maintained Hold	$41	neutral
11/22/22	Cowen and Company, LLC	Upgraded to Buy	$54	gut
11/18/22	J.P. Morgan	Upgraded to Buy		gut
11/11/22	Deutsche Bank	Upgraded to Buy	$50	gut
10/25/22	Deutsche Bank	Maintained Hold	$41	neutral
10/19/22	RBC Capital Markets	Maintained Hold	$36	neutral
10/14/22	Credit Suisse	Maintained Hold	$42	neutral
10/07/22	Mizuho	Maintained Hold	$36	neutral
10/07/22	UBS	Maintained Hold	$37	neutral
10/03/22	Evercore	Maintained Hold	$32	neutral
09/22/22	Deutsche Bank	Maintained Hold	$38	neutral
07/08/22	J.P. Morgan	Maintained Hold	$45	neutral
07/06/22	Morgan Stanley	Maintained Sell	$39	schlecht
07/05/22	RBC Capital Markets	Maintained Hold	$42	neutral
07/01/22	Deutsche Bank	Maintained Hold	$44	neutral

Walgreens Boots Alliance Estimates* in USD

	2024	2025	2026	2027	2028
Revenue	145,456	150,852	157,335	166,591	172,509
Dividend	1.53	1.39	1.33	-	-
Dividend Yield (in %)	9.48 %	8.64 %	8.29 %	-	-
EPS	3.21	3.12	3.48	3.63	4.05
P/E Ratio	5.01	5.16	4.63	4.44	3.98
EBIT	3,057	3,442	3,805	4,166	4,615
EBITDA	4,613	4,980	5,582	5,121	5,453
Net Profit	2,709	2,638	2,900	3,112	3,458
Net Profit Adjusted	2,744	2,627	2,956	3,112	3,458
Pre-Tax Profit	2,622	2,983	3,467	3,783	4,264
Net Profit (Adjusted)	1,225	2,292	2,399	-	-
EPS (Non-GAAP) ex. SOE	3.20	3.04	3.35	3.86	4.35
EPS (GAAP)	-5.40	1.91	2.45	2.13	2.55
Gross Income	27,487	28,545	30,187	32,123	33,478
Cash Flow from Investing	-648	-1,590	-1,636	-2,116	-2,391
Cash Flow from Operations	2,779	3,589	4,318	4,472	4,941
Cash Flow from Financing	-3,583	-2,695	-3,123	-1,392	-1,452
Cash Flow per Share	4.33	4.64	4.97	-	-
Free Cash Flow	1,240	2,001	2,695	2,673	3,063
Free Cash Flow per Share	4.27	-	-	-	-
Book Value per Share	15.36	16.25	17.78	-	-
Net Debt	9,751	8,831	4,519	-	-
Research & Development Exp.	-	-	-	-	-
Capital Expenditure	1,393	1,621	1,694	1,799	1,878
Selling, General & Admin. Exp.	29,016	25,598	26,948	28,795	29,706
Shareholder’s Equity	14,261	14,816	15,831	17,949	18,987
Total Assets	84,430	85,369	86,181	87,855	88,662

	Previous Quarter	Current Quarter ending 05/31/24	Next Quarter ending 08/31/24	Current Year ending 08/31/24	Next Year ending 08/31/25
Earnings Estimates
No. of Analysts	-	15	15	18	18
Average Estimate	-	0.714 USD	0.667 USD	3.211 USD	3.122 USD
Year Ago	-	1.000 USD	0.670 USD	3.980 USD	3.211 USD
Publish Date	-	3/28/2024	6/27/2024	-	-
Revenue Estimates
No. of Analysts	-	13	13	17	16
Average Estimate	-	36,003 USD	36,092 USD	145,456 USD	150,852 USD
Year Ago	-	35,415 USD	35,422 USD	139,081 USD	145,456 USD
Publish Date	-	3/28/2024	6/27/2024	-	-

* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

	2023	2022	2021	2020	2019	2018	2017
Sales	139,081.00	132,703.00	132,509.00	139,537.00	136,866.00	131,537.00	118,214.00
Change of sales in %	4.81	0.15	-5.04	1.95	4.05	11.27	0.74
Gross profit on sales	24,815.00	26,275.00	26,144.00	26,090.00	28,038.00	29,022.00	27,508.00
Gross profit on sales change in %	-5.56	0.50	0.21	-6.95	-3.39	5.50	-2.30
Operating income	2,987.00	2,771.00	4,018.00	3,747.00	5,127.00	6,306.00	6,260.00
Operating income change in %	7.80	-31.04	7.23	-26.92	-18.70	0.73	-1.71
Income before tax	-5,419.00	3,985.00	1,995.00	743.00	4,527.00	5,975.00	4,853.00
Income before tax change in %	-	99.75	168.51	-83.59	-24.23	23.12	-5.66
Income after tax	-3,080.00	4,336.00	2,220.00	456.00	3,982.00	5,024.00	4,078.00
Income after tax change in %	-	95.32	386.84	-88.55	-20.74	23.20	-2.28

Balance Sheet in Mio. USD

	2023	2022	2021	2020	2019	2018	2017
Total liabilities	68,140.00	59,716.00	57,145.00	66,038.00	43,445.00	41,435.00	37,735.00
Long-term liabilities per share	50.49	42.95	40.55	45.02	19.74	20.76	18.74
Equity	28,489.00	30,408.00	24,140.00	21,135.00	24,153.00	26,689.00	28,274.00
Equity change in %	-20.79	7.93	13.48	-12.23	-9.59	-5.31	-8.08
Balance sheet total	96,629.00	90,124.00	81,285.00	87,173.00	67,598.00	68,124.00	66,009.00
Balance sheet total change in %	7.22	10.87	-6.75	28.96	-0.77	3.20	-9.19

Key Data in USD

	2023	2022	2021	2020	2019	2018	2017
Sales per share	161.12	153.25	152.94	158.51	148.20	132.20	109.61
P/E ratio (year end quote, basic EPS)	-	7.00	19.81	73.40	11.87	13.58	21.56
P/E ratio (ear end quote, diluted EPS)	-	7.00	19.81	73.40	11.87	13.58	21.56
P/E ratio (year end quote)	-	7.00	19.81	73.40	11.87	13.58	21.56
Dividend yield in %	7.59	5.45	3.70	4.84	3.47	2.39	1.87
Equity ratio in %	20.72	28.04	28.81	23.67	34.78	38.18	41.61
Debt ratio in %	70.52	66.26	70.30	75.75	64.27	60.82	57.17

Walgreens Boots Alliance Insider Activity

Name	Date	shares traded	shares held	Price	type (sell/buy)	option
Minnix Lanesha	05/31/2024	186,136.00	186,136.00	n/a	Buy	No
Brown Tracey D	04/22/2024	3,489.00	176,380.00	18.22	Sell	No
Brown Tracey D	04/22/2024	11,594.00	179,869.00	n/a	Buy	No
Bhandari Inderpal S	04/10/2024	3,000.00	3,000.00	18.05	Buy	No
Mahajan Manmohan	04/01/2024	6,000.00	166,969.00	19.38	Buy	No
Mahajan Manmohan	02/29/2024	101,874.00	160,969.00	n/a	Buy	No
JARRETT VALERIE B	01/28/2024	4,456.00	4,456.00	22.44	Buy	No
SCHLICHTING NANCY M	01/15/2024	15,209.00	n/a	23.05	Sell	No
WENTWORTH TIMOTHY C	01/04/2024	10,000.00	585,122.00	24.22	Buy	No
Gates Richard P.	11/09/2023	1,000.00	73,929.00	20.45	Sell	No
Barra Ornella	10/31/2023	6,235.00	622,563.00	21.08	Sell	No
Heckman Todd	10/31/2023	468.00	27,774.00	21.08	Sell	No
Heckman Todd	10/31/2023	197.00	28,242.00	21.08	Sell	No
Heckman Todd	10/31/2023	174.00	28,439.00	21.08	Sell	No
Ban Kevin M.	10/31/2023	2,741.00	113,930.00	21.08	Sell	No
Ban Kevin M.	10/31/2023	321.00	116,671.00	21.08	Sell	No
Ban Kevin M.	10/31/2023	396.00	116,992.00	21.08	Sell	No
May Holly	10/31/2023	3,077.00	188,829.00	21.08	Sell	No
May Holly	10/31/2023	1,014.00	191,906.00	21.08	Sell	No
Gray Danielle	10/31/2023	3,467.00	210,301.00	21.08	Sell	No
Gray Danielle	10/31/2023	1,291.00	213,768.00	21.08	Sell	No
Brown Tracey D	10/31/2023	3,024.00	152,243.00	21.08	Sell	No
Brown Tracey D	10/31/2023	1,013.00	155,267.00	21.08	Sell	No
Gates Richard P.	10/31/2023	937.00	74,929.00	21.08	Sell	No
Gates Richard P.	10/31/2023	197.00	75,866.00	21.08	Sell	No

Walgreens Boots Alliance Dividend Calendar

Date	Name	Dividend	*yield	Currency
2023	Walgreens Boots Alliance Inc	1.92	7.59	USD
2022	Walgreens Boots Alliance Inc	1.91	5.45	USD
2021	Walgreens Boots Alliance Inc	1.88	3.70	USD
2020	Walgreens Boots Alliance Inc	1.84	4.84	USD
2019	Walgreens Boots Alliance Inc	1.78	3.47	USD
2018	Walgreens Boots Alliance Inc	1.64	2.39	USD
2017	Walgreens Boots Alliance Inc	1.53	1.87	USD
2016	Walgreens Boots Alliance Inc	1.46	1.80	USD
2015	Walgreens Boots Alliance Inc	1.37	1.59	USD
2014	Walgreens Boots Alliance Inc	1.28	2.12	USD
2013	Walgreens Boots Alliance Inc	1.14	2.37	USD
2012	Walgreens Boots Alliance Inc	1.00	2.80	USD
2011	Walgreens Boots Alliance Inc	0.80	2.27	USD
2010	Walgreens Boots Alliance Inc	0.63	2.33	USD
2009	Walgreens Boots Alliance Inc	0.50	1.48	USD
2008	Walgreens Boots Alliance Inc	0.40	1.10	USD
2007	Walgreens Boots Alliance Inc	0.33	0.73	USD
2006	Walgreens Boots Alliance Inc	0.27	0.55	USD
2005	Walgreens Boots Alliance Inc	0.22	0.47	USD
2004	Walgreens Boots Alliance Inc	0.18	0.49	USD
2003	Walgreens Boots Alliance Inc	0.16	0.49	USD
2002	Walgreens Boots Alliance Inc	0.15	0.43	USD
2001	Walgreens Boots Alliance Inc	0.14	0.41	USD
2000	Walgreens Boots Alliance Inc	0.14	0.43	USD
1999	Walgreens Boots Alliance Inc	0.13	0.57	USD

*Yield of the Respective Date

Walgreens Boots Alliance Inc Calendar

Event	Estimate	Info	Date
Press Conference	-		06/27/2024
Earnings Report	0.667 USD	Q3 2024 Earnings Release	06/27/2024
Earnings Report	-	Q4 2024 Earnings Release	10/10/2024
Earnings Report	-	Q1 2025 Earnings Release	01/02/2025
Earnings Report	-	Q2 2025 Earnings Release	03/27/2025
Earnings Report	-	Q3 2025 Earnings Release	06/26/2025

Walgreens Boots Alliance Inc Past Events

Event	Actual EPS	Info	Date
Earnings Report	-6.850 USD	Q2 2024 Earnings Release	03/28/2024
Press Conference	-	-	03/28/2024
Press Conference	-	-	01/04/2024
Press Conference	-	-	10/12/2023
Press Conference	-	-	06/27/2023

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Moody’s Daily Credit Risk Score

Risk

Low
Medium
High

Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’sbalance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of creditrisk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes intoaccount day-to-day movements in market value compared to a company’s liability structure.

Walgreens Boots Alliance Shareholder

Owner	in %
Freefloat	82.43
Stefano Pessina	16.91
The Vanguard Group, Inc.	9.64
Vanguard Group, Inc. (Subfiler)	9.16
SSgA Funds Management, Inc.	6.29
State Street Corp.	4.20
BlackRock Fund Advisors	3.64
Capital Research & Management Co. (World Investors)	3.37
Vanguard Total Stock Market ETF	2.51
Geode Capital Management LLC	2.19
Vanguard 500 Index Fund	2.13
Invesco QQQ Trust	1.92
BlackRock Institutional Trust Co. NA	1.84
Invesco Capital Management LLC	1.78
Vanguard Mid Cap Index Fund	1.74

Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

Walgreens Boots Alliance Management

Name	Job
Todd Heckman	Chief Accounting Officer, SVP & Global Controller
Timothy C. Wentworth	Chief Executive Officer & Director
Elizabeth L. Burger	Chief Human Resources Officer & Executive VP
Neal Sample	Chief Information Officer & Executive VP
Vish Sankaran	Chief Innovation Officer
Linh Peters	Chief Marketing Officer & Senior Vice President
Luke Rauch	Chief Merchandising Officer & Senior VP
Ornella Barra	Chief Operating Officer-International
Rick Gates	Chief Pharmacy Officer
Jim Townsend	Chief Procurement Officer
Bala Visalatha	Chief Product Officer & Senior Vice President
Mike Maresca	Chief Technology Officer
Anita M. Allemand	Chief Transformation & Integration Officer
Thomas E. Polen	Director
Stefano Pessina	Executive Chairman
Carlos W. Cubia	Global Chief Diversity Officer & Senior VP
Manmohan Mahajan	Global Chief Financial Officer & EVP
Lanesha T. Minnix	Global Chief Legal Officer & Executive VP
Omorlie Harris	Global Treasurer & Senior Vice President
Tiffany Kanaga	Head-Investor Relations
Robert Huffines	Independent Director
Bryan C. Hanson	Independent Director
Inderpal S. Bhandari	Independent Director
John Anthony Lederer	Independent Director
Valerie B. Jarrett	Independent Director
Nancy M. Schlichting	Independent Director
Janice May Babiak	Independent Director
Ginger L. Graham	Lead Independent Director
Juan Guerra	SVP & Managing Director-International Wholesale
Joseph B. Amsbary	Secretary & Senior Vice President
Anas Al-Hamwi	Senior Director-Safety & Injury Management
Sebastian Richard Edward James	Senior Vice President
Roger Phillips	Vice President-Global Mergers & Acquisitions

Walgreens Boots Alliance Stock Price | WBA Stock Quote, News, and History | Markets Insider (2024)